Sort
21,453 grants matching “tuberculosis”
Inhibition of methionine biosynthesis eliminates persistent M. tuberculosis.
$250,500Michael Berney · Albert Einstein College Of Medicine, Inc · R21 · FY2016 · AI
Shortening Tuberculosis Chemotherapies using N-acetylcysteine
$250,500William Robert Jacobs · Albert Einstein College Of Medicine · R21 · FY2019 · AI
Targeting mycobacterial ribosomes as a new approach to tuberculosis vaccines
$250,500Steven A Porcelli · Albert Einstein College Of Medicine, Inc · R21 · FY2018 · AI
Genetic Screens for Virulence Factors of Mycobacteria
$250,500Yeshiva University · R21 · FY2003 · AI
Sequencing Core
$250,461Gregory Seumois · La Jolla Institute For Immunology · U19 · FY2015 · AI
Minnesota-Makerere-Mbarara Neuro-Infectious Disease Research Training Consortium
$250,400David R Boulware · University Of Minnesota · D43 · FY2024 · TW
Prognostic value of quantitative HPV viral load in determining cervical cancer treatment response and recurrence
$250,392Surbhi Grover · University Of Pennsylvania · K08 · FY2022 · CA
Biochemistry of Energy-Dependent (Intracellular) Protein Degradation
$250,356Michael Maurizi · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
AGING AND IMMUNITY IN TUBERCULOSIS
$250,332Colorado State University-Fort Collins · R01 · FY2001 · AG
Tissue-specific Borrelia Gene Expression
$250,319Erol Fikrig · Yale University · R37 · FY2009 · AI
MECHANISM OF PHAGE L5 INTEGRATION AND EXCISION
$250,307University Of Pittsburgh At Pittsburgh · R01 · FY2002 · GM
Developing research leaders at the intersection of malnutrition and tuberculosis in Tanzania
$250,288Scott K Heysell · University Of Virginia · D43 · FY2022 · TW
The Function of Host-derived Extracellular Vesicles in Trafficking of Bacterial Antigens to Stimulate the Antibacterial Immune Response
$250,257Mariola Jadwiga Ferraro · University Of Florida · R01 · FY2024 · AI
KATG PEROXIDASE IN ISONIAZID ACTIVATION AND RESISTANCE
$250,250Mayo Clinic Coll Of Medicine, Rochester · R21 · FY2001 · AI
POPULATION BASED INVESTIGATIONS OF TUBERCULOSIS
$250,239Montefiore Medical Center (Bronx, Ny) · R01 · FY2001 · AI
Myeloid-Derived Suppressor Cells in Tuberculosis Granuloma Structure and Function
$250,199Amanda Martinot · Tufts University Boston · R21 · FY2021 · AI
A new essential protein kinase in Mycobacterium tuberculosis
$250,132Christoph Grundner · Seattle Biomedical Research Institute · R21 · FY2017 · AI
AIDS Malignancy Clinical Trials Consortium
$250,067Ronald T Mitsuyasu · University Of California Los Angeles · U01 · FY2008 · CA
Viral Testing Core
$250,014Koen K Van Rompay · University Of California At Davis · U42 · FY2023 · OD
Viral Testing Core
$250,014Koen K Van Rompay · University Of California At Davis · U42 · FY2021 · OD
Viral Testing Core
$250,013Koen K Van Rompay · University Of California At Davis · U42 · FY2022 · OD
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)
$250,001Michael David Hughes · Harvard School Of Public Health · UM1 · FY2023 · AI
VACCINE AND EVALUATION TREATMENT UNITS
$250,000Robert B. Belshe · Saint Louis University · N01 · FY2013 · AI
UCB/UCSF AIDS International Training and Research Program (AITRP)
$250,000Arthur L. Reingold · University Of California Berkeley · D43 · FY2013 · TW
Mechanism and Inhibition of Pyruvate Phosphate Dikinase
$250,000University Of New Mexico · R01 · FY2002 · GM